Surendra Nayak

Surendra Nayak currently serves as Scientific Associate Director at Bristol Myers Squibb, focusing on cancer drug discovery since November 2019, after previously holding positions including Senior Principal Scientist, Principal Scientist, and Senior Scientist within the same field. Prior experience includes a role as Senior Scientist at Celgene, where responsibilities encompassed cancer drug discovery, target identification, validation, and mechanism of action studies from May 2016 to November 2019. Surendra Nayak's earlier career features positions at SRI International, Exelixis, Encysive Pharmaceuticals, and the Genomics Institute of the Novartis Research Foundation, alongside postdoctoral research roles at the University of Texas Southwestern Medical Center and the National Institute of Immunology, where a Ph.D. in Biochemistry was obtained.